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Since its discovery in 1993 (1) and its
association with Sin Nombre virus in North
America (2), hantavirus pulmonary syndrome
(HPS) has been identified in several countries in
South America and is associated with Juquitiba
virus in Brazil (3), Andes virus in Argentina and
Chile (4-6), and Laguna Negra virus in Paraguay
(7,8). Hantaviruses are rodent-borne, and each is
associated with a specific primary rodent
reservoir. Sigmodontine rodents are the vectors
of hantaviruses associated with HPS (3).
Case Report
A 20-year-old male resident of Santiago,
Chile, who had no prior history of medical
problems, became ill after he backpacked (from
February 4 to March 9, 1997) as a tourist in
Bolivia. His travel itinerary included Barrio,
Oruro, La Paz, Cochabamba, Villa Tunari, Santa
Cruz, Vallegrande, Higueras, and Sucre. The
tourist and a fellow traveler stayed in hotel in
Santa Cruz where they saw black rats running
through the bathroom they used. While in
Higueras, they stayed in a rustic adobe house
with no floor and joined local villagers in
agricultural jobs, primarily harvesting hay. A
diagnosis of HPS was considered.
On March 26, 3 weeks after returning to
Chile, the young man became ill with fever and
cough. On March 28, he was admitted to the
emergency room of a private hospital in Santiago
with high fever (39°C), cough, and chest pain.
Chest X-rays showed interstitial infiltrates in the
left lower lobe. Laboratory results were as
follows: hemoglobin 15.3 gm/dl, white blood cells
5,900, platelets 130,000, erythrocyte sedimenta-
tion rate 6, and a C-reactive protein 2.8 mg/dl. He
was sent home on clarithromycin 250 mg, twice a
day. Three days later (March 31), he returned to
the emergency room with persistent high fever,
myalgia, and shortness of breath; distal cyanosis
was noted. Vital signs were as follows: blood
pressure 115/80, pulse 120, temperature 38.5°C,
and respiratory rate 32. Physical examination
found few petechiae on the forearms, diffuse
bilateral rales, regular cardiac rhythm, no
murmurs, and no hepatomegaly or splenomegaly.
Chest X-rays showed diffuse bilateral alveolar
infiltrates. Oxygen saturation was 90%. Labora-
tory values included white blood cells 11,700 with
a left shift, platelets 150,000, hemoglobin 19.4,
erythrocyte sedimentation rate 2, C-reactive
protein 8.18, INR 1.6, activated partial thrombo-
plastin 43s, blood urea nitrogen 38.9 mg/dl, and
liver function tests normal limits.
The patient was transferred to the intensive
care unit with a diagnosis of bilateral pneumonia
of unknown etiology and secondary respiratory
failure. In 3 to 4 hours, acute respiratory distress
developed; arterial blood gases (on 50% oxygen)
were PaO2 61, PaCO2 22.7, pH 7.49, and HCO3
17.1. The patient was connected to a ventilator
and was started on imipenen, erythromycin,
amantadine, dopamine, dobutamine, fluids, and
nitric oxide. Two 500-mg doses of methylpred-
nisolone were administered, and a Swan-Ganz
catheter was installed. The pulse wedge pressure
was 7, and the cardiac output 6.1. During the first
24 hours, acute renal failure developed, and
hemodialysis was started.
Hypotension was quite refractory to vasoac-
tive drugs (mean BP 30 to 40), and critical
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hypoxemia (O2 saturation 70% to 80%) and
hypotension persisted for 48 hours.
Echocardiography showed a mild pericardial
effusion. Blood cultures were negative for
bacteria, as well as for influenza, adenovirus,
respiratory syncytial virus, and parainfluenza
virus. Serologic results for Mycoplasma,
Legionella, and HIV were also negative. Blood
gases started to improve on day 3, and the
patient’s clinical condition also slowly improved.
On day 10, hemolytic anemia (Coombs negative)
developed, and a bone marrow aspirate showed
hemophagocytosis. On day 11, an episode of
bleeding from the respiratory tract occurred.
However, the patient’s ventilatory function
continued to improve. On day 15 after admission,
his chest X-ray was clearing, but he was still on a
mechanical ventilator (O2 saturation 98% on 40%
O2). However, he was anuric (BUN 100). On day
17, he had a second episode of bronchial bleeding,
and bronchoscopy showed only a 4-mm tracheal
ulcer. Platelets were 72,000, and hematocrit fell
to 24%. Hantavirus serology was reported
positive [Centers for Disease Control and
Prevention (CDC), April 18], and intravenous
ribavirin was started on April 22. A central
venous catheter-related infection with Pseudomo-
nas and Staphylococcus aureus was documented.
The patient’s condition deteriorated progres-
sively, with further bronchial bleeding and
markedly unstable ventilatory function, and
required constant administration of vasoactive
drugs; he died of massive pulmonary hemorrhage
and shock on April 28. A postmortem lung sample
was taken with a needle.
The patient’s serum, collected on April 1, was
tested for immunoglobulin G (IgG) and IgM
antibodies to Sin Nombre virus at CDC. Both IgG
and IgM antibodies were found, which suggested
recent infection with a hantavirus associated
with Sigmodontine rodents. Subsequent testing
of sera collected on April 21 and April 25
confirmed the initial findings. Hematoxylin and
eosin stained sections of the lung sample showed
diffuse alveolar damage with extensive hyaline
membrane formation, proliferation of type II
pneumocytes, and fibroblastic and edematous
thickening of alveolar walls. Abundant fibrin,
necrotic debris, and acute inflammatory cellular
infiltrates were also observed in the alveolar
spaces. Rare endothelial cells and macrophages
were hantavirus-antigen positive by previously
described immunohistochemical procedures (9).
The destructive changes seen by histopathology
and a small amount of antigen found in the
patient’s tissues are compatible with the long
course of the patient’s illness (9).
Viral RNA was extracted from the earliest
serum sample, and reverse transcriptase-
polymerase chain reaction amplification with
primers designed specifically for hantaviruses
associated with Sigmodontine rodents (8) yielded
polymerase chain reaction fragments for the S
and M segments. These cDNA fragments were
sequenced and compared with those of other
American hantaviruses. These comparisons show
that the virus is closely related to other South
American hantaviruses, and most closely related
to Laguna Negra virus detected in patients and
Calomys laucha rodents (vesper mice) in the
Chaco region of Paraguay (7,8). The nucleotide
sequence identity was 84% for the G1 protein
encoding fragment and 87% for the N protein
encoding fragment. However, the deduced amino
acid sequences for both fragments were identical
to Laguna Negra virus. This shows that the virus
associated with this HPS case is a Laguna Negra
virus variant and suggests that the virus is
probably associated with the same or a very
closely related species of rodent host.
C. laucha, the apparent primary rodent
reservoir for Laguna Negra virus, is common in
savanna and grassland areas as far north as
southern Brazil and Bolivia, throughout much of
Paraguay and Uruguay, and in Argentina as far
south as Rio Negro province, but not in Chile (10).
A number of the lowland rural locations that the
patient visited in Bolivia are within the range of
C. laucha.
The clinical course and travel history of the
patient and the laboratory serology and
molecular characterization of the viral RNA are
compatible with infection in Bolivia with a
Laguna Negra virus variant. This report and
evolving information concerning hantaviruses
associated with clinical HPS in Argentina and
Paraguay strongly suggest that a diagnosis of
HPS should be considered in patients with febrile
respiratory distress syndrome throughout Latin
America.
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